Article

Allergan enters patent battle over generic version of brimonidine tartrate solution

Irvine, CA-Allergan Inc. said it has filed a lawsuit against Alcon Laboratories Inc. claiming that the Fort Worth, TX company infringed upon Allergan's patents for brimonidine tartrate ophthalmic solution 0.15% to manufacture a generic alternative to its Alphagan P drops.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.